This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Ten Years Later

Marcello Puggiari, MD; Michael Cherington, MD

JAMA. 1978;240(21):2276-2277.

Abstract
Guanidine hydrochloride was introduced as an adjunct in the treatment of botulism in 1968. It has been reported to be of benefit in 39 cases and of no benefit in 13 cases. No serious side effects have occurred with the short-term therapy required in botulism. Our two cases are similar to earlier cases in that the improvement seen with guanidine therapy is most notable in ocular muscles and least notable in respiratory muscles. Electrophysiological findings again showed an increase in the amplitude of evoked muscle-action potentials after guanidine administration.

(JAMA 240:2276-2277, 1978)

Author Affiliations
From the Department of Neurology, University of Colorado Medical Center, Denver.

Footnotes
Read in part before the 24th annual meeting of the American Association of Electromyography and Electrodiagnosis, Salt Lake City, Oct 1, 1977.

Reprint requests to Department of Neurology, University of Colorado Medical Center, 4200 E Ninth Ave, Denver, CO 80262 (Dr Cherington).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Wound Botulism in Pediatrics
Keller et al.
Arch Pediatr Adolesc Med 1982;136:320-322.
ABSTRACT